Quality of diagnostic staging in patients with bladder cancer: A process-outcomes link

Cancer

Volumn 121, Issue 3, 2015, Pages 379-385

  Chamie, Karim ^a   Ballon Landa, Eric ^b,c   Bassett, Jeffrey C ^a   Daskivich, Timothy J ^a   Leventhal, Meryl ^d   Deapen, Dennis ^d   Litwin, Mark S ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bladder cancer mortality; Pathology; Quality of health care; Urinary bladder neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER SURGERY; CANCER GRADING; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; DETRUSOR MUSCLE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NON MUSCLE INVASIVE BLADDER CANCER; PATHOLOGIST; REGRESSION ANALYSIS; TRANSURETHRAL RESECTION OF BLADDER TUMOR; TUMOR INVASION; UNITED STATES; UROLOGIST; CYSTECTOMY; PATHOLOGY; PROCEDURES; SMOOTH MUSCLE; STANDARDS; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; LOS ANGELES; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM STAGING; SEER PROGRAM; URINARY BLADDER NEOPLASMS;

EID: 84921449573     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29071     Document Type: Article

References (20)

1. Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64:639-653.
2. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 2007;178:2314-2330.
3. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer. 2009;115:988-996.
4. Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol. 2003;169:110-115.
5. Badalato GM, Gaya JM, Hruby G, et al. Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference? BJU Int. 2012;110:1471-1477.
6. Herr HW, Sogani PC. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol. 2001;166:1296-1299.
7. Mariappan P, Finney SM, Head E, et al. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int. 2012;109:1666-1673.
8. Dalbagni G, Vora K, Kaag M, et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol. 2009;56:903-910.
9. Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol. 1999;162:74-76.
10. Cina SJ, Epstein JI, Endrizzi JM, Harmon WJ, Seay TM, Schoenberg MP. Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. Hum Pathol. 2001;32:630-637.
11. Richards B, Parmar MK, Anderson CK, et al. Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group. Br J Urol. 1991;67:369-375.
12. Comperat E, Egevad L, Lopez-Beltran A, et al. An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps. Histopathology. 2013;63:756-766.
13. Jimenez RE, Keane TE, Hardy HT, Amin MB. pT1 urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications. Adv Anat Pathol. 2000;7:13-25.
14. Lopez-Beltran A, Cheng L. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. Pathology. 2003;35:484-491.
15. Maruniak NA, Takezawa K, Murphy WM. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol. 2002;167:2404-2407.
16. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
17. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48:817-830.
18. Huber PJ. The Behavior of Maximum Likelihood Estimates Under Nonstandard Conditions. Berkeley, CA: University of California Press; 1967.
19. Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57:843-849.
20. Skolarus TA, Ye Z, Montgomery JS, et al. Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. Urology. 2011;78:1345-1349.